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Abstract
Background: Functional loss of the tumor suppressor Smad4 is involved in pancreatic and colorectal
carcinogenesis and has been associated with the acquisition of invasiveness. We have previously demonstrated
that the heterotrimeric basement membrane protein laminin-332 is a Smad4 target. Namely, Smad4 functions as a
positive transcriptional regulator of all three genes encoding laminin-332; its loss is thus implicated in the reduced
or discontinuous deposition of the heterotrimeric basement membrane molecule as evident in carcinomas.
Uncoupled expression of laminin genes, on the other hand, namely overexpression of the laminin-g2 chain is an
impressive marker at invasive edges of carcinomas where tumor cells are maximally exposed to signals from
stromal cell types like macrophages. As Smad4 is characterized as an integrator of multiple extracellular stimuli in a
strongly contextual manner, we asked if loss of Smad4 may also be involved in uncoupled expression of laminin
genes in response to altered environmental stimuli. Here, we address Smad4 dependent effects of the prominent
inflammatory cytokine TNFa on tumor cells.
Results: Smad4-reconstituted colon carcinoma cells like adenoma cells respond to TNFa with an increased
expression of all three chains encoding laminin-332; coincubation with TGFb and TNFa leads to synergistic
induction and to the secretion of large amounts of the heterotrimer. In contrast, in Smad4-deficient cells TNFa can
induce expression of the g2 and b3 but not the a3 chain. Surprisingly, this uncoupled induction of laminin-332
chains in Smad4-negative cells rather than causing intracellular accumulation is followed by the release of g2 into
the medium, either in a monomeric form or in complexes with as yet unknown proteins. Soluble g2 is associated
with increased cell migration.
Conclusions: Loss of Smad4 may lead to uncoupled induction of laminin-g2 in response to TNFa and may
therefore represent one of the mechanisms which underlie accumulation of laminin-g2 at the invasive margin of a
tumor. The finding, that g2 is secreted from tumor cells in significant amounts and is associated with increased cell
migration may pave the way for further investigation to better understand its functional relevance for tumor
progression.
Background
In normal tissues, the epithelium is separated from the
underlying mesenchyme by the basement membrane
(BM), a specialized sheet of the extracellular matrix.
The BM is built from constituents produced by both the
epithelial and the mesenchymal cells [1,2]. Whereas
collagen IV is the most prominent mesenchymal derived
component providing the structural scaffold of the BM
sheet the epithelial derived laminins build the center-
piece of the network that harbors additional proteins
including perlecan, nidogen and fibulin [3]. The base-
ment membrane has been recognized as a structural but
also as an important functional component of tissues. In
particular, the laminins mediate cellular functions
including adhesion, migration, growth and tissue-specific
gene expression [4,5].
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with at least 15 different isoforms composed of different
combinations of one a-, one b-a n do n eg-chain, each,
out of five a,t h r e eb and three g-chains. The laminins
are expressed in a tightly regulated development- and
differentiation-specific pattern [6-8]. In the adult human
intestine, laminins-211 and -511 show complementary
distributions along the crypt-villus axis, whereas lami-
nin-332 is restricted to the villus regions. In premalig-
nant stages of colorectal carcinogenesis, namely in
different types of adenomas, normal expression and
deposition of laminin-332 and -511 has been reported.
The transition to malignancy is defined by breaking the
basement membrane barrier. In colorectal carcinomas,
this is associated with a lack of laminin-511 and with
irregular deposition of laminin-332 at invasive edges
[9-11]. Relative overexpression of the laminin-g2( a n d
b3) chain has often been described and represents one
of the most impressive molecular markers for the inva-
sive front of colorectal and other cancer entities (for
review see [12]). It specifically marks socalled budding
tumor cells [13,14]. Laminin-g2 has been described as a
target gene of the Wnt/b-catenin pathway [15]. Whereas
b-catenin is constitutively activated through mutation of
the tumor suppressor APC in the majority of adenomas
the relative overexpression of g2a tt h ei n v a s i v ee d g eo f
carcinomas requires additional alterations. Overexpres-
sion of g2 is believed to result from cellular responses to
environmental signals illustrating that the regulation of
laminin expression is subject to tumor cell intrinsic fac-
tors including the pattern of their respective genetic
alterations and to extrinsic microenvironmental factors
including signals from inflammatory cells in the tumor
tissue.
We have recently identified laminin-332 as a target
structure of the tumor suppressor Smad4 [16]. We have
shown that Smad4 functions as a positive transcriptional
regulator of all three chains encoding laminin-332.
Reexpression of Smad4 led to the increased expression
of heterotrimeric laminin-332 and to its deposition in
basement membrane-like structures at contact sites with
fibroblasts. Loss of Smad4 in the carcinogenic process,
in turn, is implicated in reduced or absent expression of
laminin-332 in poorly differentiated carcinomas.
Smads are primarily characterized as transmitters of
signals from the TGFb superfamily of cytokines but also
function as promiscuitive transcriptional coregulators
that can interact with a variety of ubiquitous and tissue-
specific transcription factors and coregulators in a
context-dependent manner [17,18]. TGFb, in Smad4-
reexpressing cancer cells like in premalignant adenoma
cells induces the expression of all three genes encoding
heterotrimeric laminin-332 whereas Smad4-negative
cells are non-responsive [16,19]. The underlying
molecular mechanisms are surprisingly complex and
involve transcription factor binding sites like AP1 which
are targeted by various signaling cascades. Moreover,
the modular composition of the three promoters signifi-
cantly differs from each other; a functional smad bind-
ing element (SBE) is present exclusively in the LAMA3
promoter [19]. Thus, we wonder if the consequences of
Smad4 loss in response to extracellular signals other
than TGFb may differ between the three genes encoding
laminin-332. As an approach towards modelling the
cytokine environment in tumor tissues we here address
effects of TNFa, a prominent inflammatory cytokine
produced by tumor infiltrating macrophages, on lami-
nin-332 expression in Smad4-positive and Smad4-defi-
cient tumor cells.
We report, that Smad4-reexpressing human colorectal
cancer cells like adenoma cells respond to TNFa with a
moderate increase of all three chains encoding laminin-
332 and with synergistic induction in response to the
combination of TGFb and TNFa. In contrast, their
Smad4-deficient counterparts display uncoupled
responses to TNFa:w h e r e a st h eb3c h a i na n di np a r t i -
cular the g2 chain is strongly induced in Smad4-negative
cells, induction of the a3 chain is Smad4-dependent and
is mediated via an NF-Bs i t ea n dd o w n s t r e a mA P 1
sites in the LAMA3 promoter. Of note, TNFa induction
leads to the release of significant amounts of the g2
chain in a monomeric form and in complex with (an)
unknown protein(s) as shown by Western blotting
under non-reducing conditions and confirmed by mass
spectrometry. Ultimately, induced secretion of soluble
g2 by transient suppression of the a3 chain leads to
induction of cell migration.
Results
Synergistic induction of laminin-332 in human adenoma
cells in response to inflammatory cytokines TGFb and
TNFa
As an approach towards modelling the microenviron-
ment in tumor tissues we here wished to address effects
of TNFa, a prominent inflammatory cytokine produced
by tumor infiltrating macrophages, on laminin-332
expression of Smad4-positive and Smad4-deficient
tumor cells. We use the human adenoma cell line LT97
carrying mutations of the APC and Ki-ras genes [20] as
a model for early stage premalignant tumor cells with
intact Smad4. We have reported previously, that LT97
cells respond to the treatment with TGFb with tran-
scriptional induction of all three genes encoding lami-
nin-332 [16]. Here, LT97 cells were incubated with
TNFa alone or in combination with TGFb.T h e r ew a s
no evidence for TNFa induced cell death in LT97 cells.
Interestingly, whereas treatment with TNFa alone
induced a moderate increase in the release of the
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cytokines led to induced secretion of laminin-332 to an
enormous extent (approximately 14-fold) (Figure 1A).
Western blotting under reducing conditions with lami-
nin chain-specific antibodies confirmed that the hetero-
trimer is composed of the a3, b3a n dg2c h a i n s ,a s
expected (data not shown). Laminin-332 specific tran-
scripts are barely detectable in LT97 cells cultured in
the absence of cytokines but are strongly induced in
response to TGFb, as reported previously [16]. TNFa
treatment alone also induced the expression of all three
genes. The combination of both cytokines led to a very
strong synergistic induction particularly of the mRNA of
a3 and g2 chains (Figure 1B).
Synergistic effect of TGFb and TNFa on the secretion of
heterotrimeric laminin-332 by Smad4-reconstituted
human colorectal cancer cells and uncoupled responses
of Smad4-deficient cells
We next sought to analyse laminin expression in
Smad4-deficient and Smad4-reexpressing SW480 and
SW620 human colon cancer cells in response to TNFa
and to the combination of TGFb and TNFa cytokines.
SW480 cells manipulated to reexpress Smad4 after ret-
roviral transduction have been described previously [19];
unlike SW480 cells expressing very low levels of Smad4
after stable transfection [21], moderate Smad4 overex-
pression in this cellular model is adequate to restore
TGFb responsiveness. Likewise, Smad4-reexpressing
SW620 cell clones displayed similar restoration of TGFb
responsiveness in transient transfection assays with the
currently used p3TPlux and p6SBE promoter-reporter
constructs (Additional file 1).
The secretion of laminin-332 could barely be detected
in uninduced SW480 and SW620 cells and in cells
induced with both cytokines separately (Figure 2A and
2B). In contrast, when cells were coinduced with both
cytokines, Smad4-positive SW480 and SW620 cells but
not their Smad4-negative counterparts showed secretion
of significant levels of laminin-332 (Figure 2A and 2B)
indicating that this response is Smad4-dependent.
We next performed expression analyses at the mRNA
level in both cell lines at two different time points (at 4
a n d2 4h )o fi n d u c t i o nw i t hc y t o k i n e s( F i g u r e2 Ca n d
Additional file 2). As reported previously [16,19], reex-
pression of Smad4 induced slight increases of basal
expression levels of all three laminin-332 chains and
restored their TGFb-responsiveness (Figure 2C and
Additional file 2). In contrast, TNFa induced expression
of the LAMB3 and LAMC2 genes in Smad4-negative
cells to a similar or even to a larger extent as compared
to Smad4-positive cells. Compared to TNFa responses
alone, coinduction with both cytokines did not signifi-
cantly alter responses in Smad4-negative cells. In
Figure 1 Synergistic induction of laminin-332 in human
adenoma cells in response to inflammatory cytokines TGFb
and TNFa. (A) Western blot analysis of heterotrimeric laminin-332
expressed by LT97 colorectal adenoma cells. Proteins (8 μg/lane)
prepared from serum-free conditioned media from LT97 cells
treated with recombinant TGFb and TNFa for 48 h as indicated
were separated on 3-8% tris-acetate gradient gels (Invitrogen) under
non-reducing conditions. The blot was probed with a laminin-g2-
specific antibody (polyclonal antibody 2140, PS-A) and reprobed
with a transferrin-specific antibody used as a loading control. The
bars indicate the relative signal strength normalized for transferrin.
Note that the Odyssey detection system (LI-COR) allows for a direct
digital quantification of signals. Similar results were obtained in >
three experiments. The same signals, although with less sensitivity,
were obtained using a commercial antibody (MAB-19562,
Chemicon). (B) Northern blot analyses of the LAMA3, LAMB3 and
LAMC2 genes prepared with RNAs from LT97 cells treated with
cytokines for 24 h. Quantification of mRNA levels was done by
phosphorimage analysis and signal strengths normalized with
GAPDH. Similar results were obtained in three experiments.
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was induced in an additive or synergistic manner by
both cytokines. Of note, responses of the LAMA3 gene
significantly differed from responses of the LAMB3 and
LAMC2 genes: Smad4-negative cells display no or negli-
gible induction of LAMA3 expression in response to
TNFa alone and to the combination of TNFa and
TGFb in both cell lines and at both time points ana-
lysed. In contrast, Smad4-positive SW620 (but not
SW480 cells) displayed responsiveness to TNFa alone
(Figure 2C and Additional file 2); both, Smad4-positive
SW480 and SW620 cells, showed additive or synergistic
responses to the combination of both cytokines (Figure
2C and Additional file 2). This expression pattern was
consistent with the strongly increased amounts of
secreted laminin-332 heterotrimer by Smad4-reexpres-
sing cells in response to combined treatment with TGFb
and TNFa. In addition, these results suggested that loss
of Smad4 was responsible for uncoupled regulation of
the three laminin genes in response to TNFa.
TNFa induced secretion of monomeric laminin-g2b y
Smad4-deficient colorectal cancer cells
Assembly of the heterotrimeric protein is believed to be
a prerequisite for secretion of laminin. Having shown
uncoupled induction of g2 we searched for an intracellu-
lar accumulation of the protein by Western blotting but
we could not discern specific bands in cell lysates. An
analysis of the laminin-332 heterotrimer in conditioned
media by Western blotting with a g2-specific antibody
under non-reducing conditions had previously shown
additional diffuse signals at smaller protein sizes in lanes
loaded with conditioned media proteins from TNFa
treated Smad4-negative cells. A systematic analysis with
gel conditions adapted revealed distinct bands corre-
sponding to a protein size of roughly 240 and 140 kilo-
dalton (kDa) with a commercial g2-specific monoclonal
antibody (MAB 19562, Chemicon) (data not shown). An
independent g2-specific antiserum (polyclonal, 2140)
delivered an identical pattern (Figure 3A). This result
was confirmed with a set of each, three independent
Smad4-deficient and Smad4-reexpressing SW620 cell
clones (Figure 3B). Thus, Smad4-deficient SW620 cells
in response to TNFa apparently release the laminin-g2
c h a i ni nam o n o m e r i cf o r ma n di nac o m p l e xw i t h
another unknown protein. Under reducing conditions,
Smad4-deficient cells showed the unprocessed form of
the g2 chain at 140 kDa, only. Laminin-g2c h a i n s
derived from the Smad4-positive cells came as a mixture
of the unprocessed form and a processed form at a size
of roughly 105 kDa suggesting that processing may
occur in the heterotrimeric configuration (Figure 3C).
Mass spectrometry based confirmation of secreted
laminin-g2
To unequivocally confirm the specificity of the Western
blot signals we performed proteomic analysis of condi-
tioned media of Smad4-negative SW620 cells treated
Figure 2 Synergistic effect of TGFb and TNFa on the secretion of heterotrimeric laminin-332 by Smad4-reconstituted human
colorectal cancer cells and uncoupled responses of Smad4-deficient cells. (A and B) Western blot analysis of proteins from conditioned
media (12 μg of protein per lane) produced by SW480 (A) and SW620 (B) cells as described in figure 1. (C) Northern Blot analysis with RNAs
from SW620 cells treated with cytokines for 4 h. Shown in each bar is the mean +/- standard error (n = 3). The additional file 2 provides
additional data for SW620 cells treated with cytokines for 24 hours and data for SW480 cells treated with cytokines for 4 and 24 hours.
Zboralski et al. Molecular Cancer 2010, 9:65
http://www.molecular-cancer.com/content/9/1/65
Page 4 of 13with TNFa by nanoscale liquid chromatography tandem
mass spectrometry (nano-LC/MS/MS). Slices were cut
form a non-reducing preparative gel corresponding to
the 140 kDa signal (band 1) and to the 240 kDa region
(band 2). Two slices corresponding to the putative het-
erotrimer signals (bands 3 and 4) were included as posi-
tive controls (Figure 4A). The laminin-g2-specific
peptides identified in gel band 1 are indicated in the
amino acid sequence in figure 4B. All results of mass
spectrometry and database searches are shown in addi-
tional file 3 and summarized in table 1. Among 52 pro-
teins identified in total in gel band 1 the laminin-g2
chain had the highest Mascot score and highest number
of spectral counts which is an indirect measure for its
relative abundance [22]. Likewise, laminin-g2r a n k e da t
position 3 according to the Mascot score among pro-
teins identified in band 2 which corresponds to the
Western blot signal at 240 kDa. Also, all three laminin
chains were among the most abundant proteins in band
4 according to both their Mascot scores and spectral
counts, the presumptive heterotrimer. Band number 3
which corresponds to the second slightly smaller signal
and was regarded as a processed laminin-332 heterotri-
mer provided surprising results: Whereas the g2c h a i n
ranked at position 5 with 26 spectral counts, the a3 and
b3 chains come at ranks 42 (spectral count 3) and 50
(spectral count 2), only, indicating that their relative
amounts are much lower as compared to laminin-g2.
This, in turn, suggests that the Western blot signal at
approximately 400 kDa like the signal at 240 kDa corre-
sponds to a protein complex of laminin-g2w i t h( a n )a s
yet unknown protein(s).
Induced release of monomeric laminin-g2 upon transient
laminin-a3 knockdown in SW620 cells and its impact on
cell migration
N e x t ,w ew i s h e dt og e ts o m ei n s i g h ti n t ot h ef u n c t i o n a l
consequences of laminin-g2 release. Accumulation of
laminin-g2 marks the invasive margin of tumors, suggest-
ing that laminin-g2 is associated with migratory activity.
As reexpression of Smad4 induces comprehensive altera-
tions of expression profiles and profoundly affects cellu-
lar behaviour through diverse mechanisms, the
comparison of Smad4-deficient and Smad4-reexpressing
Figure 3 TNFa induced secretion of monomeric laminin-g2 by Smad4-deficient colorectal cancer cells. (A) Western blot analysis of
proteins from conditioned media produced by SW620 cells in response to treatment with recombinant TGFb and TNFa for 48 h under non-
reducing conditions. Proteins (16 μg/lane) were separated by SDS-PAGE on 8% polyacrylamide gels, blotted and probed with a laminin-g2-
specific antibody (2140). (B) A set of each, three independent Smad4-deficient and Smad4-reexpressing SW620 cell clones were treated with
TNFa and conditioned media analysed like in (A). (C) Protein samples corresponding to those used in (A) were analyzed under reducing
conditions.
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tive impact of monomeric laminin-g2 on cellular migra-
tion. Therefore, we set up transient knockdown of
LAMA3 expression in order to specifically induce lami-
nin-g2 monomer secretion in response to TNFa.I nf a c t ,
transient knockdown of LAMA3 proved functional as
assessed by Northern blot analysis (Figure 5A). Suppres-
sion of LAMA3 expression resulted in a twofold increase
in the 240 and 140 kDa laminin-g2 signals in conditioned
media from TNFa-incubated Smad4-negative SW620
cells (and at very low levels in media from Smad4-posi-
tive cells) (Figure 5B). The heterotrimeric laminin-332 in
Smad4-positive SW620 cells treated with TNFa was
reduced upon transient LAMA3 knockdown as expected
(Figure 5B). We then performed transwell migration
assays. Both, Smad4-deficient and Smad4-positive cells
displayed approximately doubled migration efficiencies
upon induced release of laminin-g2 (and reduced release
of heterotrimeric laminin-332) through LAMA3 knock-
down (Figure 5C).
Smad4-dependent response of LAMA3 to TNFa is
partially mediated via an NF-B site
We have shown previously, that the molecular mechan-
isms underlying Smad4-mediated TGFb responses sig-
nificantly differ between the three promoters;
specifically, the LAMA3 promoter, only, harbours a
functional SBE. Here we first asked if this peculiarity of
the LAMA3 promoter may also somehow be involved in
Smad4-dependent responses to TNFa.
A luciferase construct harbouring the 2 kb region
upstream promoter region from the transcription start
site reflected TNFa responses of the endogenous
LAMA3 gene (Figure 6). Responses to a corresponding
construct with the SBE site at position -1.5 kb mutated
were indistinguishable (data not shown). In silico analy-
sis revealed that this promoter region harbors two
Figure 4 Mass spectrometry-based confirmation of secreted
laminin-g2. (A) Preparative gel electrophoresis of conditioned
media from SW620 cells (Smad4-deficient) treated with TNFa.A n
8% SDS-PAGE was performed with preparative amounts of protein
(32 μg) in the middle lane and analytical amounts of protein
(16 μg) in the left and right lanes under non-reducing conditions.
The left and right lanes were used for Western blotting with a
laminin-g2-specific antibody. Four small slices (1-2 mm)
corresponding to the Western blot signals were cut from the
preparative gel lane and proteins analysed by mass spectrometry.
(B) Amino acid sequence of laminin-g2. The peptides identified by
mass spectrometry in gel bands 1-4 are indicated.
Table 1 Mass spectrometry of proteins and protein
complexes reactive with laminin-g2 specific antibodies as
indicated in Figure 4a
band 1
140 kDa
band 2
240 kDa
band 3
400 kDa
band 4
> 460 kDa
Laminin-g2 1* (42)
[1349.7]
3* (22)
[637]
5* (26)
[734]
3* (40)
[1305.3]
Laminin-b3 - - 51* (2)
[85.1]
4* (40)
[1263.9]
Laminin-a3 38* (3) [67.1] - 43* (3)
[117]
2* (48)
[1320.8]
Total no of
proteins
identified
52 28 82 81
*Rank, (spectral counts), [Mascot Score]; Rank according to spectral counts as
a quantitative measure for the relative abundance of proteins
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Page 6 of 13Figure 5 Induced release of monomeric laminin-g2 upon transient laminin-a3 knockdown in SW620 cells and its impact on cell
migration. (A) Northern blot analysis of LAMA3 knockdown in SW620 cells. RNAs were prepared from SW620 cells transiently transfected with
LAMA3 siRNA and incubated with TNFa for 24 h. Quantification of LAMA3 messages normalized for GAPDH is indicated. (B) Western blot
analysis of laminin-g2 expression upon transient knockdown of LAMA3. SW620 cells transiently transfected with LAMA3 siRNA or non-targeting
siRNA were shifted to serum-free cultures 48 h after transfection and were incubated with TNFa for another 48 h. Proteins from conditioned
media (16 μg/lane) were probed with a laminin-g2-specific antibody (2140). Quantification of the monomer and of the heterotrimer normalized
for transferrin is indicated. (C) Migration of SW620 cells as analyzed in a transwell migration assay. SW620 cells transfected with LAMA3 siRNA or
non-targeting siRNA were plated in a transwell chamber 24 h after transfection. TNFa was added one day later. Migrating cells were quantified
after three days using Cell Titer Glo assay (Promega). Bars show the mean value of four experiments with the standard error of the mean.
Statistical analysis was carried out by t test (one-tailed, GraphPad Prism 4.00).
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Mutation of the upstream NF-B site strongly reduced
TNFa-inducibility of LAMA3 in Smad4-positive cells
but did not affect LAMA3 responses in Smad4-negative
cells. Mutation of the downstream site was without
effect. AP1 sites have previously been shown to be
involved in basal and TGFb-induced LAMA3 expression
[19]. Mutation of the most upstream AP1 site at posi-
tion -272 also led to reduced TNFa inducibility of
LAMA3 expression in Smad4-positive cells and
completely abolished the low-level TNFa inducibility of
LAMA3 expression in Smad4-negative cells. In sum-
mary, we here have implicated an NF-Bs i t ea n dt oa
lesser extent an AP1 site in Smad4-dependent TNFa
induction of LAMA3 expression.
In contrast, mutation of a (cryptic) NF-B binding site
at position -166, the only NF-B binding site within
the 0.8 kb promoter fragment of LAMC2, did not
reduce TNFa inducibility (data not shown). AP1 sites
previously implicated in TGFb induction of LAMB3 and
Figure 6 Analysis of regulatory sites involved in TNFa responses of the LAMA3 promoter by transient transfection of promoter-
reporter constructs. Normalized promoter activities of LAMA3 wild-type and mutated promoter constructs. SW480 cells were plated in 96-well
plates and transfected with the indicated promoter constructs using the Dual-Luciferase-Reporter Assay System (Promega). An NF-B site is
involved in promoter responses in Smad4-positive but not in Smad4-negative cells. An AP1 site is involved in TNFa responsiveness in a Smad4-
independent manner. Bars show the mean value of three approaches with the standard error of the mean. Statistical analysis was carried out by
t test (one-tailed, GraphPad Prism 4.00). *P < 0.05, **P < 0.01.
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genes in Smad4-positive and in Smad4-negative cells
(Additional file 4).
Discussion
Invading tumor cells are maximally exposed to growth fac-
tors and cytokines expressed by stromal cell types. Among
these, macrophages have previously been shown to induce
angiogenesis [23] and to enhance invasion through the
secretion of TNFa [24]. TNFa in cooperation with TGFb
dramatically enhanced EMT [24]. On the other hand nor-
mal intestinal epithelial cells respond to TNFa and TGFb
with an increase in the expression of heterotrimeric lami-
nin-332 [25]. We therefore focused on the analysis of
laminin-332 expression in response to cytokines TGFb
and TNFa in cell models adequate to reflect the molecular
progression of colorectal cancer in vitro. To this end we
used pairs of cell clones derived from the human Smad4-
deficient colorectal cancer cell lines SW480 and SW620,
in which Smad4 expression was stably restored. Responses
of Smad4-reexpressing cancer cells were compared to
responses of LT97 cells, a cell line derived from a late ade-
noma and carrying inactivated APC as well as an activated
Ki-ras oncogene [20]. LT97 cells secreted increased
amounts of heterotrimeric laminin-332 in response to
TGFb and TNFa, respectively, and showed extensive
synergistic induction of laminin-332 in response to the
combination of both cytokines. Smad4-reexpressing colon
cancer cells displayed similar, although less pronounced
effects. These results are consistent with observations in
vivo, that colorectal adenoma cells in the vicinity of infil-
trating inflammatory cells display thickening of the base-
ment membrane with streak-like deposits of laminin-332
[10]. Likewise, intestinal epithelial cells in patients afflicted
with Morbus Crohn show increased levels of TNFa and
induced expression of the constituents of laminin-332
[26,27]. The response of (normal and) premalignant cells
to increase expression of laminin-332 may thus be inter-
preted as a defense mechanism against an inflammatory
attack by strengthening the basement membrane barrier.
Synergistic induction of laminin-332 in response to
TGFb and TNFa was Smad4-dependent as it did not
occur in Smad4-deficient SW480 and SW620 cells.
Smad4-deficient cells can induce the expression of the
(b3a n d )g2 chain of laminin-332 in response to TNFa
whereas TNFa induction of the a3c h a i ni sS m a d 4 -
dependent. These results indicate that loss of Smad4 may
represent a genetic alteration in the carcinogenic process
that can lead to uncoupled regulation of the three genes
encoding laminin-332 in response to inflammatory cyto-
kines. We have shown previously that the molecular
mechanisms of Smad4-dependent regulation of the three
promoters encoding laminin-332 are surprisingly com-
plex. Concerning basal and TGFb-induced expression
levels Smad4 is essential for positive regulation of all
three genes. The molecular mechanisms underlying this
regulation, however, are significantly divergent between
the LAMA3 promoter as compared to the LAMB3 and
LAMC2 promoters [19]. Here we show that Smad4 is
essential for TNFa induction of LAMA3 but not of
L A M B 3a n dL A M C 2a n dt h a tA P 1a n dN F - B sites are
involved in TNFa-mediated Smad4-dependent LAMA3
induction. Unraveling transcription factor complexes
built in response to cytokines and active at the three pro-
moters will require further detailed analyses.
We here focus on functional consequences of
uncoupled regulation of the three laminin-332 chains in
response to TNFa. The prevailing view suggests that the
b3 and g2 chains first form a heterodimer intracellularly,
which then binds to a3 followed by rapid secretion of
the heterotrimer [28]. Uncoupled induction at the
mRNA level in response to TNFa therefore let us
expect an intracellular accumulation of the g2 chain in
Smad4-deficient cells. Despite repeated attempts, how-
ever, intracellular g2c o u l dn o tb ed e t e c t e db yW e s t e r n
blotting of cell homogenates. Rather, Smad4-deficient
cells release the g2 chain in a monomeric form and in
two complexes with as yet unidentified proteins as
shown by Western blotting and unequivocally confirmed
by mass spectrometry.
What are the functional implications of the release of
monomeric g2? We have shown here, that increased
amounts of g2 are associated with increased migration
and assume that secreted g2 may somehow promote
tumor invasion. The release of g2m a yi m p i n g eo nt h e
composition of the extracellular matrix, alter its func-
tional characteristics and so indirectly affect cell adhe-
sion and migration. Interaction of g2 with various ECM
molecules including collagen, perlecan and fibulin has
been reported [29,30]. Alternatively, monomeric g2m a y
directly affect the tumor cells by interacting with cellu-
lar receptors followed by effects on cell signaling which
subsequently may result in cell migration. The predomi-
nant laminin-receptors are the integrins. Whereas inter-
action of laminin-332 with cells is predominantly
mediated via integrins a3b1o ra6b4t h r o u g hb i n d i n g
to the laminin-like globular domains of the a3 laminin
chain, the g2 chain can bind to a2b1 integrin [30].
Interestingly, it is known that domain III of the g2
chain can also directly interact with the EGF-receptor
[31]. EGF signaling is a major stimulus for cell
migration.
Clues to the functional relevance of g2 secreted from
cells may come from further analysis of g2 complexes in
conditioned media. Western blotting as well as results
from mass spectrometry indicated that similar amounts
of g2 are present under non-reducing conditions at
140 kDa corresponding to the monomeric form and at
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we assume that the laminin-g2c h a i nm a yi n t e r a c tw i t h
another protein of approximately 100 kDa in size. The
proteomic analysis surprisingly provided evidence for
another as yet unknown g2 complex of about 400 kDa
in size. As soon as alternative g2 binding partners will
be identified their functional relevance for tumor cell
migration and invasion can be addressed.
In summary, our results provide evidence for a
sequence of events, in which loss of the Smad4 leads to
induction of the laminin g2 chain in response to TNFa
followed by the release of monomeric laminin g2w h i c h
exerts a proinvasive effect. In conclusion, we here sug-
gest a novel mechanism that may underlie the switch to
invasive tumor growth upon loss of the tumor suppres-
sor Smad4.
A large variety of growth factors and cytokines can be
expressed at the invasive margin of carcinomas; some of
them have previously been suspected to underlie relative
overexpression of g2. For example, Olsen at al. investi-
gated the involvement of HGF and found synergistic
induction of g2b u tn o ta3 by HGF and TGFb [32].
LAMC2 is an established b-catenin target gene and
nuclear b-catenin has been reported to correlate with
intracellular accumulation of g2 at invasive margins and
in budding tumor cells [15]. Thus, upstream ligands of
the wnt gene family induced upon cancer progression
may also represent putative inducers of overexpressed
g2. Interestingly, the expression of wnts 2 and 5 has
specifically been found in macrophages associated with
colon tumors [33]. Activated macrophages can indirectly
promote Wnt signaling through TNFa [34,35]. We here
present data showing that tumor cell responses to
TNFa and to the combination of TNFa and TGFb cri-
tically depend on Smad4. As extensive crosstalk
mechanisms exist between Wnt/b-catenin and TGFb/
Smad pathways [36-38] the detailed understanding of
laminin regulation will require future investigations
based on an integrated view of signaling networks in
normal and oncogenically programmed cells and their
respective responses to a dynamic cytokine milieu.
Conclusions
The laminin-g2 chain, which is physiologically deposited
in basement membranes as a component of the hetero-
trimeric laminin-332, is an impressive marker of invasive
margins of aggressive carcinomas. In the present study
we show that loss of the tumor suppressor Smad4 may
be one of the molecular mechanisms that can lead to
this relative overexpression of the laminin-g2 chain in
response to the inflammatory cytokine TNFa. Moreover,
we show that this uncoupled expression leads to the
release of laminin-g2 which in turn promotes tumor cell
migration. We have thus unraveled a novel molecular
mechanism of how loss of the tumor suppressor Smad4
may promote the carcinogenic process in vivo, where
tumor cells interact with stromal cell types and respond
to inflammatory cytokines like TNFa expressed by
macrophages at the tumor host interface.
Methods
Cell culture and conditioned media
The human colorectal carcinoma cell lines SW480 and
SW620 were obtained from the American Type Culture
Collection, the human colon adenoma cell line LT97-2
was kindly provided by M Marian (Vienna, Austria).
LT97 cells were maintained in Ham’s F12 medium with
supplements as described [20]. All other cells were
maintained in Dulbecco’s Modified Eagle Medium
(DMEM) supplemented with 10% fetal calf serum,
2 mM glutamine, 100 U/mL penicillin and 100 μg/mL
streptomycin. When indicated, cells were incubated
with 5 ng/mL of TGFb1 (R&D systems, Minneapolis,
MN, USA) and 30 ng/mL of TNFa (Pan Biotech,
Aidenbach, Germany) in serum reduced medium (0.5%
FCS). Preparation of proteins from serum-free condi-
tioned media was performed as described previously
[39].
Production of polyclonal antibody 2140
GST-tagged recombinant laminin-g2 was produced by
expressing pGEX g2lam5 (kindly provided by Dr. M. Failla,
IDI-IRCCS, Roma, Italy) in E.coli. Affinity-purified laminin
g2-GST protein was confirmed by mass spectrometry
(LSMDO, CNRS-EPCM, UMR7509, Strasbourg, France)
and injected into rabbits. Antibodies were verified by
immunoblotting on HT29-MTX cells and by immuno-
fluorescence on human intestines (not shown) giving iden-
tical but stronger signals than MAB19562 (Chemicon,
Hampshire, UK).
Western blotting and RNA analyses
For laminin Western blots, samples were subjected to
SDS-PAGE on either 8% polyacrylamide gels or on
NuPAGE Novex 3-8% Tris-Acetate gels (Invitrogen,
Karlsruhe, Germany) and run under conditions either
with (reducing conditions to analyze single chain
expression) or without dithiothreitol (non-reducing
reducing conditions). Heterotrimeric laminin-332,
dimeric and monomeric laminin-g2 under non-reducing
conditions were detected with monoclonal antibody
MAB19562 (Chemicon) and polyclonal antibody 2140.
The blots were incubated with a secondary antibody
directly coupled with a fluorescent dye (Alexa Fluor
680; Alexa Fluor 800; Invitrogen and Rockland). Signals
were detected using the Odyssey Infrared Imaging Sys-
tem (LI-COR Biosciences, Bad Homburg, Germany)
which allows for a digital quantification of signals over
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were performed according to standard procedures by
Northern blot hybridization and by qRT-PCR as
described previously [16,19,21].
Mass spectrometry and mass spectrometric data analysis
Mass spectrometry and mass spectrometric analysis are
described in detail in the additional information. In
brief, tryptic digest were analyzed by nano-HPLC/ESI-
MS/MS using the UltiMate™ 3000 HPLC system (Dionex
LC Packings, Idstein, Germany) online coupled to an
LTQ Orbitrap XL instrument (Thermo Fisher Scientific,
Bremen, Germany). Reversed-phase (RP) capillary HPLC
separations were performed as described previously [40].
Peak lists of MS/MS spectra were imported into Protein-
Scape (version 1.3, Bruker Daltonics, Bremen, Germany)
and subsequently correlated with the human International
Protein Index database (human IPI v3.41, http://www.ebi.
ac.uk) containing 72155 protein entries using MASCOT
(release version 2.2) [41]. To enable the estimation of a
false discovery rate (FDR), the database was concatenated
with a duplicate of itself in which the amino acid sequence
of each protein entry was randomly shuffled [42]. Protein
hits up to an accumulated FDR of 5% were considered as
true positive identifications.
Migration assay and transient LAMA3 knockdown
Cells in 500 μL media were added to the upper com-
partment of 12 well plates supplemented with inserts (8
μm pore size; BD Falcon). Cytokines were added one
day later and cells incubated for another 72 hours at
37°C. Cells which had passed the pore membrane
were quantified using Cell Titer Glo (Promega, Madison,
WI, USA) in accordance with the manufacturer’s
recommendations.
For siRNA experiments cells were grown to a con-
fluency of 50% and transfected with ON-TARGETplus
siRNA (LAMA3, J-011071-05, Dharmacon, Lafayette,
CO, USA) or Dharmacon ON-TARGETplus Nontarget-
ing siRNA as a control, respectively, using Dharmafect
(Dharmacon). For migration assays cells were plated
into transwells 24 h after transfection.
Promoter analyses
Promoter construction and transient transfections were
performed as previously described [16,19] with minor
modifications. Cells were grown to a confluency of
approximately 50-70% in 96-well plates, medium was
changed to serum reduced medium (0.5% FCS) and cells
were transfected using Effectene (Qiagen, Hilden, Ger-
many). The next day cytokines were added and cells
were harvested 4 h and 24 h after transfection. Lucifer-
ase assays were carried out as triplicates and quantified
using a luminometer (GloMax™ 96 Microplate, Promgea,
Madison, WI, USA) and the Dual-Luciferase-Reporter
Assay System (Promega).
Additional file 1: Restoration of TGFb responsiveness through re-
expression of Smad4. Smad4 expression was stably restored by
retroviral transduction in Smad4-deficient human SW620 colon
carcinoma cells. (A) Western blot analysis for the human Smad4 protein
on total protein extracts of each three Smad4-negative and six Smad4-
positive clones of SW620 cells (TJ: empty vector control clones, DTJ:
Smad4- (DPC4) positive clones). (B and C) Transient transfections with
p3Tplux (B) and p6SBE (C) reporter vectors of each four Smad4-negative
and five Smad4-positive derivates of SW620 cells. Normalized promoter
activity of p3Tplux (a fusion construct of the PAI-1 and collagenase-1
promoters harboring AP1 sites) and p6SBE (a 6fold concatemer of the
SBE) as analyzed in transient transfections of TGFb-treated (24 h) and
-untreated Smad4 negative and Smad4 re-expressing cells. Transient
transfection experiments were repeated in triplicates. The bars show the
mean values with the standard error of the mean. For further
experiments we defined a standard clone set consisting of clones TJ3, 9
and 10 and DTJ8, 16 and 21.
Additional file 2: Synergistic effect of TGFb and TNFa on the
expression of LAMA3, LAMB3 and LAMC2 genes by Smad4-
reconstituted human colorectal cancer cells and uncoupled
responses of Smad4-deficient cells. (A and B) Semi-quantitative RT-
PCR analysis of the LAMA3, LAMB3 and LAMC2 genes prepared with
RNAs from SW480 cells treated with recombinant TGFb and TNFa for 4 h
(A) and 24 h (B). Shown in each bar is the mean +/- standard error of 10
measurements. (C) Northern blot analysis of the LAMA3, LAMB3 and
LAMC2 genes prepared with RNAs from SW620 cells treated with
recombinant TGFb and TNFa for 24 h. Signals were quantified by
phosphorimage analysis and normalized for GAPDH expression (n = 3).
Additional file 3: Mass spectrometry of proteins and protein
complexes reactive with laminin-g2 specific antibodies as indicated
in Figure 4a. Proteins were identified through SDS-PAGE combined with
nano-high performance liquid chromatography coupled online with
electrospray ionization tandem mass spectrometry. MS/MS data were
used for protein identification by performing searches in the human IPI
database with Mascot and for the calculation of spectral counts as a
relative quantitative measure for protein abundance. Proteins were
identified with a false discovery rate of 5%.
Additional file 4: TNFa induction of LAMB3 and LAMC2 is conferred
through AP1 binding sites. Normalized promoter activities of LAMB3
(A) and LAMC2 (B) wild-type and mutated promoter constructs. SW480
cells were plated in 96-well plates and transfected with the indicated
promoter constructs using the Dual-Luciferase-Reporter Assay System
(Promega). Mutagenesis of both AP1 sites in the LAMB3 promoter
significantly reduced TNFa responsiveness in Smad4 reexpressing cells.
TNFa induction of LAMC2 is conferred through the upstream AP1 site in
a Smad4-independent manner. Bars show the mean value of three
experiments with the standard error of the mean.
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